Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents. 2013

Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
Department of Pharmaceutical Chemistry, Indo-Soviet Friendship (ISF) College of Pharmacy, Moga, India; drrajiv81@yahoo.in

Colon-specific azo based prodrugs of anticancer agents like methotrexate (6), gemcitabine (7) and analogue of oxaliplatin (RTB-4) (8) were synthesized and characterized by modern analytical techniques. The prepared prodrugs were stable in acidic (pH 1.2) and basic (pH 7.4) buffers which showed their stability in upper GIT environment. Further, an assay was performed which demonstrated the presence of azoreductase enzyme in the rat fecal material, rat cecum content and other parts of intestinal content which reduce specifically the azo bond and release the drug. The in vitro cytotoxicity assay was also performed which clearly indicated that these azo based prodrugs are active against human colorectal cancer cell lines (COLO 205, COLO 320 DM and HT-29). The release behavior of prodrugs (10, 11 and 15) was 60-70% after 24h incubation at 37°C. Therefore, the synthesized azo linked prodrugs of methotrexate, gemcitabine and RTB-4 are the potential candidates for colon targeted drug delivery system with minimal undesirable side effects.

UI MeSH Term Description Entries
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001391 Azo Compounds Organic chemicals where aryl or alkyl groups are joined by two nitrogen atoms through a double bond (R-N Azo Dye,Azo Dyes,Compounds, Azo,Dye, Azo,Dyes, Azo
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
October 2017, Future medicinal chemistry,
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
June 2021, Molecules (Basel, Switzerland),
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
January 2013, European journal of medicinal chemistry,
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
January 2011, Current topics in medicinal chemistry,
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
June 2007, Combinatorial chemistry & high throughput screening,
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
April 2005, European journal of medicinal chemistry,
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
February 2007, Bioorganic & medicinal chemistry,
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
October 2023, Bioorganic & medicinal chemistry letters,
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
June 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Rajiv Sharma, and Ravindra K Rawal, and Tripti Gaba, and Nishu Singla, and Manav Malhotra, and Sahil Matharoo, and T R Bhardwaj
January 2018, PloS one,
Copied contents to your clipboard!